Related Experiment Video
Updated: Jul 16, 2026
12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.1K
2-Bromopalmitate depletes lipid droplets to inhibit viral replication
Dongxiao Liu1, Ruth Cruz-Cosme1, Yong Wu2
1Department of Microbiology, Howard University College of Medicine, Washington, DC, USA.
Journal of Virology
|March 15, 2024
Summary
2-bromopalmitate (2 BP) effectively inhibits viral replication by depleting lipid droplets (LDs), a novel mechanism beyond palmitoylation inhibition. This discovery offers a new strategy for developing broad-spectrum antivirals targeting LDs.
Area of Science:
- Virology
- Cell Biology
- Biochemistry
Background:
- Emerging viral infections necessitate broad-spectrum antiviral therapies.
- Lipid droplets (LDs) are cellular organelles exploited by viruses for replication.
- Targeting LDs presents a promising strategy for antiviral development as their depletion does not harm cell survival.
Purpose of the Study:
- To investigate the antiviral efficacy of palmitoylation inhibitors, specifically 2-bromopalmitate (2-BP), 2-fluoro palmitic acid (2-FPA), and cerulenin.
- To elucidate the mechanism underlying 2-BP's potent antiviral activity, particularly its effect on LDs.
- To highlight the role of LDs in viral replication and their potential as antiviral targets.
Main Methods:
- Comparative analysis of 2-BP, 2-FPA, and cerulenin on viral replication and palmitoylation.
- Assessment of LD depletion and viral replication in the presence of these inhibitors and oleic acid.
- Fatty acid (FA) assays to determine intracellular FA distribution.
Main Results:
- 2-BP demonstrated superior inhibition of viral replication compared to 2-FPA and cerulenin, despite similar palmitoylation inhibition.
- 2-BP uniquely depleted LDs, a phenomenon not observed with 2-FPA or cerulenin.
- LD depletion by 2-BP was directly linked to its antiviral effect, as oleic acid supplementation rescued both LDs and viral replication.
Conclusions:
- The primary antiviral mechanism of 2-BP involves LD depletion, not solely palmitoylation inhibition.
- LDs play a critical role in viral replication, making them a viable target for antiviral intervention.
- This study uncovers a novel biological activity of 2-BP and contributes to developing novel broad-spectrum antiviral strategies targeting LDs.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...